Cargando…

Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy

Immunogenic programmed cell death, such as pyroptosis and ferroptosis, efficiently induces an acute inflammatory response and boosts antitumor immunity. However, the exploration of dual-inducers, particularly nonmetallic inducers, capable of triggering both pyroptosis and ferroptosis remains limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liang, Song, An, Yang, Qi-Chao, Li, Shu-Jin, Wang, Shuo, Wan, Shu-Cheng, Sun, Jianwei, Kwok, Ryan T. K., Lam, Jacky W. Y., Deng, Hexiang, Tang, Ben Zhong, Sun, Zhi-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475094/
https://www.ncbi.nlm.nih.gov/pubmed/37660063
http://dx.doi.org/10.1038/s41467-023-41121-z
_version_ 1785100645698633728
author Zhang, Liang
Song, An
Yang, Qi-Chao
Li, Shu-Jin
Wang, Shuo
Wan, Shu-Cheng
Sun, Jianwei
Kwok, Ryan T. K.
Lam, Jacky W. Y.
Deng, Hexiang
Tang, Ben Zhong
Sun, Zhi-Jun
author_facet Zhang, Liang
Song, An
Yang, Qi-Chao
Li, Shu-Jin
Wang, Shuo
Wan, Shu-Cheng
Sun, Jianwei
Kwok, Ryan T. K.
Lam, Jacky W. Y.
Deng, Hexiang
Tang, Ben Zhong
Sun, Zhi-Jun
author_sort Zhang, Liang
collection PubMed
description Immunogenic programmed cell death, such as pyroptosis and ferroptosis, efficiently induces an acute inflammatory response and boosts antitumor immunity. However, the exploration of dual-inducers, particularly nonmetallic inducers, capable of triggering both pyroptosis and ferroptosis remains limited. Here we show the construction of a covalent organic framework (COF-919) from planar and twisted AIEgen-based motifs as a dual-inducer of pyroptosis and ferroptosis for efficient antitumor immunity. Mechanistic studies reveal that COF-919 displays stronger near-infrared light absorption, lower band energy, and longer lifetime to favor the generation of reactive oxygen species (ROS) and photothermal conversion, triggering pyroptosis. Because of its good ROS production capability, it upregulates intracellular lipid peroxidation, leading to glutathione depletion, low expression of glutathione peroxidase 4, and induction of ferroptosis. Additionally, the induction of pyroptosis and ferroptosis by COF-919 effectively inhibits tumor metastasis and recurrence, resulting in over 90% tumor growth inhibition and cure rates exceeding 80%.
format Online
Article
Text
id pubmed-10475094
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104750942023-09-04 Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy Zhang, Liang Song, An Yang, Qi-Chao Li, Shu-Jin Wang, Shuo Wan, Shu-Cheng Sun, Jianwei Kwok, Ryan T. K. Lam, Jacky W. Y. Deng, Hexiang Tang, Ben Zhong Sun, Zhi-Jun Nat Commun Article Immunogenic programmed cell death, such as pyroptosis and ferroptosis, efficiently induces an acute inflammatory response and boosts antitumor immunity. However, the exploration of dual-inducers, particularly nonmetallic inducers, capable of triggering both pyroptosis and ferroptosis remains limited. Here we show the construction of a covalent organic framework (COF-919) from planar and twisted AIEgen-based motifs as a dual-inducer of pyroptosis and ferroptosis for efficient antitumor immunity. Mechanistic studies reveal that COF-919 displays stronger near-infrared light absorption, lower band energy, and longer lifetime to favor the generation of reactive oxygen species (ROS) and photothermal conversion, triggering pyroptosis. Because of its good ROS production capability, it upregulates intracellular lipid peroxidation, leading to glutathione depletion, low expression of glutathione peroxidase 4, and induction of ferroptosis. Additionally, the induction of pyroptosis and ferroptosis by COF-919 effectively inhibits tumor metastasis and recurrence, resulting in over 90% tumor growth inhibition and cure rates exceeding 80%. Nature Publishing Group UK 2023-09-02 /pmc/articles/PMC10475094/ /pubmed/37660063 http://dx.doi.org/10.1038/s41467-023-41121-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhang, Liang
Song, An
Yang, Qi-Chao
Li, Shu-Jin
Wang, Shuo
Wan, Shu-Cheng
Sun, Jianwei
Kwok, Ryan T. K.
Lam, Jacky W. Y.
Deng, Hexiang
Tang, Ben Zhong
Sun, Zhi-Jun
Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
title Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
title_full Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
title_fullStr Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
title_full_unstemmed Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
title_short Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
title_sort integration of aiegens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475094/
https://www.ncbi.nlm.nih.gov/pubmed/37660063
http://dx.doi.org/10.1038/s41467-023-41121-z
work_keys_str_mv AT zhangliang integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT songan integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT yangqichao integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT lishujin integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT wangshuo integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT wanshucheng integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT sunjianwei integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT kwokryantk integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT lamjackywy integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT denghexiang integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT tangbenzhong integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy
AT sunzhijun integrationofaiegensintocovalentorganicframeworksforpyroptosisandferroptosisprimedcancerimmunotherapy